David M Euhus

Title: David M Euhus: Innovator in Cancer Diagnostics

Introduction

David M Euhus is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer diagnostics through his innovative work. His research focuses on the detection of urinary tumor-associated antigens, which has implications for early cancer diagnosis and treatment.

Latest Patents

David M Euhus holds a patent for a method of detection of urinary tumor-associated antigen. This invention describes the Urinary Tumor Associated Antigen (UTAA), its isolation, and its use in diagnostic assays. The patent highlights that UTAA has been identified in samples from cancer patients, sometimes as part of an immune complex with UTAA-specific immunoglobulin. Additionally, isolated UTAA may be formulated as a pharmaceutical for the production of antibodies or as a vaccine.

Career Highlights

Throughout his career, David has focused on advancing medical diagnostics, particularly in oncology. His work has the potential to improve patient outcomes by enabling earlier detection of tumors. His innovative approach to utilizing urinary biomarkers represents a significant advancement in cancer research.

Collaborations

David has collaborated with esteemed colleagues, including Donald L Morton and Rishab K Gupta. These partnerships have fostered a collaborative environment that enhances the development of diagnostic technologies.

Conclusion

David M Euhus is a pioneering inventor whose work in cancer diagnostics is making a difference in the medical field. His contributions, particularly in the detection of urinary tumor-associated antigens, are paving the way for improved diagnostic methods and patient care.